@FiercePharma: Novartis flu vaccines cleared in Italy: Gov't lifts suspension on Agrippal and Fluad. Release | Follow @FiercePharma
> AstraZeneca ($AZN) will pay as much as $11 million to settle antitrust litigation that alleged the company kept copycats of the heart drug Toprol XL from reaching the market. Story
> Novartis ($NVS) reports that its plant in Colorado has gotten an affirmative review by the FDA perhaps putting its problems there behind it. Story
> Denmark-based Lundbeck is opening a manufacturing plant in Tianjin, China to make drugs for the market there. Item
> Takeda is expanding its efforts in vaccines to take advantage of that growing market. Story
@FierceMedDev: Covidien's Q4 dipped over last year; the company blames currency fluctuations and an extra selling week in 2011. More | Follow @FierceMedDev
@MarkHFierce: CardiAQ Valve Technologies, based in CA, raised $32.5 million, according to a regulatory filing. More | Follow @MarkHFierce
@DamianFierce: St. Jude has won a legal injunction in its ongoing spat with supplier AorTech. News | Follow @DamianFierce
> GE grabs U-Systems to boost its breast imaging capabilities. Article
> Baxter recalls infusion sets over deadly embolism risk. News
Biotech News
@FierceBiotech: More from FierceBiotechResearch.com: Harvard's microchip, lined with living cells, mimics disease in preclinical drug test. More | Follow @FierceBiotech
@JohnCFierce: CVS blocking drugs on formulary based on price, part of the payer backlash. Also adding a few back in after discounts. News (sub. req.) | Follow @JohnCFierce
@RyanMFierce: Bristol-Myers struck a discovery deal with Chiromics , focused on small molecules in multiple diseases. Release | Follow @RyanMFierce
> Takeda takes aim at becoming next big vaccine developer. Report
> Cardioxyl Pharma reports $28M equity round with lead drug against heart failure. News
> GSK reports letdown in PhIII malaria vaccine study. Article
> Gates Foundation backs $13M venture add for flu drug developer. News
> FDA advisers endorse Novo Nordisk's key diabetes drug. Story
And Finally... Two people were killed in an explosion in Canada at the Neptune Technologies & Bioressources plant where the company makes products such as Omega-3 derived from krill. Story